Rare Cannabinoid Company Releases Guide to Endocannabinoid System
Hawaii-based Rare Cannabinoid Company has launched a new educational resource detailing the endocannabinoid system and the interactions of various cannabinoids, including CBD, THC, and CBG.
Rare Cannabinoid Company, a Hawaii-based wellness firm focused on hemp-derived products, has released a new guide explaining the human endocannabinoid system and its relationship with various cannabinoids.
The educational resource delves into the mechanisms of the endocannabinoid system and explores the distinct interactions of CBD, THC, CBG, CBN, CBC, THCV, and CBDV. The company specializes in the development and marketing of minor and rare cannabinoids.
This publication aims to provide consumers and industry professionals with a more comprehensive understanding of how these compounds work. The guide highlights the differences and potential effects of these lesser-known compounds compared to more common ones like CBD and THC.
Rare Cannabinoid Company stated the guide is part of its commitment to educating the public about the complexities of cannabinoids and promoting informed use.